Please enable JavaScript to continue using this application.

Compare $UNCY vs $XGN | Chartloom

Compare

$UNCY vs $XGN

Unicycive Therapeutics Inc · Exagen Inc

UNCY

Unicycive Therapeutics Inc

XGN

Exagen Inc

Compare $UNCY vs $XGN

Comparing Unicycive Therapeutics Inc and Exagen Inc

UNCYUnicycive Therapeutics Inc

XGNExagen Inc

UNCYUnicycive Therapeutics Inc

Market cap

$110M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.31x

Rev growth (TTM)

—

YTD performance

-29.1%

52W performance

-13.8%

FCF yield

-25.4%

XGNExagen Inc

Market cap

$203M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.63x

Rev growth (TTM)

20.8%

YTD performance

39.4%

52W performance

-23.3%

FCF yield

-3.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

UNCY

XGN

Detailed metrics comparison

UNCY

Unicycive Therapeutics Inc

XGN

Exagen Inc

Market Cap

UNCY$110M

XGN$203M

Enterprise Value

UNCY$66M

XGN$204M

Price

UNCY$4.11

XGN$8.42

P/E Ratio

UNCYN/A

XGNN/A

P/S Ratio

UNCY31.15x

XGN2.86x

EV/Sales

UNCY0.00x

XGN2.87x

EV/EBITDA

UNCY0.00x

XGN0.00x

P/B Ratio

UNCY2.21x

XGN16.60x

P/FCF Ratio

UNCYN/A

XGNN/A

EV/FCF

UNCY-2.35x

XGN-26.94x

PEG Ratio

UNCYN/A

XGNN/A

Forward P/E (NTM)

UNCYN/A

XGNN/A

Forward P/S (NTM)

UNCY0.31x

XGN2.63x

Revenue (TTM)

UNCY$0

XGN$71M

Revenue Growth (YoY)

UNCYN/A

XGN20.8%

Forward Rev Growth

UNCY37378.0%

XGN10.1%

Gross Margin (TTM)

UNCY0.0%

XGN58.6%

Operating Margin (TTM)

UNCY0.0%

XGN0.0%

EBITDA Margin (TTM)

UNCY0.0%

XGN-15.1%

Net Margin (TTM)

UNCY0.0%

XGN-26.6%

FCF Margin (TTM)

UNCYN/A

XGN-10.7%

Net Income (TTM)

UNCY$-35M

XGN$-19M

FCF (TTM)

UNCY$-28M

XGN$-8M

EPS (TTM)

UNCY-$1.31

XGN-$0.78

ROE (TTM)

UNCY-8881.0%

XGN-12162.0%

ROA (TTM)

UNCY-5966.0%

XGN-3368.0%

ROIC (TTM)

UNCY-8881.0%

XGN-4566.0%

Cash

UNCY$44M

XGN$25M

Debt

UNCY$0

XGN$26M

Net Cash/Debt

UNCY$44M

XGN$-959K

Current Ratio (TTM)

UNCY3.81x

XGN3.18x

Quick Ratio (TTM)

UNCY3.28x

XGN2.75x

Debt/Equity (TTM)

UNCY0.00x

XGN2.09x

Debt/Assets (TTM)

UNCY0.0%

XGN0.0%

Interest Coverage (TTM)

UNCYN/A

XGNN/A

Net Debt/EBITDA (TTM)

UNCY0.00x

XGN0.00x

Beta

UNCY1.78

XGN2.28

52W Performance

UNCY-13.8%

XGN-23.3%

YTD Performance

UNCY-29.1%

XGN39.4%

% from 52W High

UNCY-53.0%

XGN-31.2%

% from 52W Low

UNCY4.6%

XGN225.1%

Asset Turnover (TTM)

UNCY0.05x

XGN1.27x

FCF Yield (TTM)

UNCY-25.4%

XGN-3.7%

Earnings Yield (TTM)

UNCY-32.1%

XGN-9.3%

Dividend Yield (TTM)

UNCYN/A

XGNN/A

Rule of 40

UNCY0.0

XGN10.2

EV/GP/RG

UNCYN/A

XGN0.55

Ticker research

View UNCY research View XGN research

Metric	UNCY Unicycive Therapeutics Inc	XGN Exagen Inc
Market & Valuation
Market Cap	$110M	$203M
Enterprise Value	$66M	$204M
Price	$4.11	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	31.15x	2.86x
EV/Sales	0.00x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.21x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.35x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.31x	2.63x
Revenue & Growth
Revenue (TTM)	$0	$71M
Revenue Growth (YoY)	N/A	20.8%
Forward Rev Growth	37378.0%	10.1%
Profitability
Gross Margin (TTM)	0.0%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-15.1%
Net Margin (TTM)	0.0%	-26.6%
FCF Margin (TTM)	N/A	-10.7%
Net Income (TTM)	$-35M	$-19M
FCF (TTM)	$-28M	$-8M
EPS (TTM)	-$1.31	-$0.78
ROE (TTM)	-8881.0%	-12162.0%
ROA (TTM)	-5966.0%	-3368.0%
ROIC (TTM)	-8881.0%	-4566.0%
Financial Health
Cash	$44M	$25M
Debt	$0	$26M
Net Cash/Debt	$44M	$-959K
Current Ratio (TTM)	3.81x	3.18x
Quick Ratio (TTM)	3.28x	2.75x
Debt/Equity (TTM)	0.00x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.78	2.28
52W Performance	-13.8%	-23.3%
YTD Performance	-29.1%	39.4%
% from 52W High	-53.0%	-31.2%
% from 52W Low	4.6%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	1.27x
FCF Yield (TTM)	-25.4%	-3.7%
Earnings Yield (TTM)	-32.1%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	10.2
EV/GP/RG	N/A	0.55
Ticker research	View UNCY research	View XGN research

Valuation

P/S Ratio

XGN

2.86x

UNCY

31.15x

EV/FCF

XGN

-26.94x

UNCY

-2.35x

Growth & revenue

Revenue Growth TTM

XGN

20.8%

Forward Revenue Growth

UNCY

37378.0%

XGN

10.1%

Profitability & performance

Gross Margin

XGN

58.6%

UNCY

0.0%

ROE

UNCY

-8881.0%

XGN

-12162.0%

FCF Yield %

XGN

-3.7%

UNCY

-25.4%

52-Week Performance

UNCY

-13.8%

XGN

-23.3%

Detailed metrics comparison

UNCY

Unicycive Therapeutics Inc

XGN

Exagen Inc

Market Cap

UNCY$110M

XGN$203M

Enterprise Value

UNCY$66M

XGN$204M

Price

UNCY$4.11

XGN$8.42

P/E Ratio

UNCYN/A

XGNN/A

P/S Ratio

UNCY31.15x

XGN2.86x

EV/Sales

UNCY0.00x

XGN2.87x

EV/EBITDA

UNCY0.00x

XGN0.00x

P/B Ratio

UNCY2.21x

XGN16.60x

P/FCF Ratio

UNCYN/A

XGNN/A

EV/FCF

UNCY-2.35x

XGN-26.94x

PEG Ratio

UNCYN/A

XGNN/A

Forward P/E (NTM)

UNCYN/A

XGNN/A

Forward P/S (NTM)

UNCY0.31x

XGN2.63x

Revenue (TTM)

UNCY$0

XGN$71M

Revenue Growth (YoY)

UNCYN/A

XGN20.8%

Forward Rev Growth

UNCY37378.0%

XGN10.1%

Gross Margin (TTM)

UNCY0.0%

XGN58.6%

Operating Margin (TTM)

UNCY0.0%

XGN0.0%

EBITDA Margin (TTM)

UNCY0.0%

XGN-15.1%

Net Margin (TTM)

UNCY0.0%

XGN-26.6%

FCF Margin (TTM)

UNCYN/A

XGN-10.7%

Net Income (TTM)

UNCY$-35M

XGN$-19M

FCF (TTM)

UNCY$-28M

XGN$-8M

EPS (TTM)

UNCY-$1.31

XGN-$0.78

ROE (TTM)

UNCY-8881.0%

XGN-12162.0%

ROA (TTM)

UNCY-5966.0%

XGN-3368.0%

ROIC (TTM)

UNCY-8881.0%

XGN-4566.0%

Cash

UNCY$44M

XGN$25M

Debt

UNCY$0

XGN$26M

Net Cash/Debt

UNCY$44M

XGN$-959K

Current Ratio (TTM)

UNCY3.81x

XGN3.18x

Quick Ratio (TTM)

UNCY3.28x

XGN2.75x

Debt/Equity (TTM)

UNCY0.00x

XGN2.09x

Debt/Assets (TTM)

UNCY0.0%

XGN0.0%

Interest Coverage (TTM)

UNCYN/A

XGNN/A

Net Debt/EBITDA (TTM)

UNCY0.00x

XGN0.00x

Beta

UNCY1.78

XGN2.28

52W Performance

UNCY-13.8%

XGN-23.3%

YTD Performance

UNCY-29.1%

XGN39.4%

% from 52W High

UNCY-53.0%

XGN-31.2%

% from 52W Low

UNCY4.6%

XGN225.1%

Asset Turnover (TTM)

UNCY0.05x

XGN1.27x

FCF Yield (TTM)

UNCY-25.4%

XGN-3.7%

Earnings Yield (TTM)

UNCY-32.1%

XGN-9.3%

Dividend Yield (TTM)

UNCYN/A

XGNN/A

Rule of 40

UNCY0.0

XGN10.2

EV/GP/RG

UNCYN/A

XGN0.55

Ticker research

View UNCY research View XGN research

Metric	UNCY Unicycive Therapeutics Inc	XGN Exagen Inc
Market & Valuation
Market Cap	$110M	$203M
Enterprise Value	$66M	$204M
Price	$4.11	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	31.15x	2.86x
EV/Sales	0.00x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.21x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.35x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.31x	2.63x
Revenue & Growth
Revenue (TTM)	$0	$71M
Revenue Growth (YoY)	N/A	20.8%
Forward Rev Growth	37378.0%	10.1%
Profitability
Gross Margin (TTM)	0.0%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-15.1%
Net Margin (TTM)	0.0%	-26.6%
FCF Margin (TTM)	N/A	-10.7%
Net Income (TTM)	$-35M	$-19M
FCF (TTM)	$-28M	$-8M
EPS (TTM)	-$1.31	-$0.78
ROE (TTM)	-8881.0%	-12162.0%
ROA (TTM)	-5966.0%	-3368.0%
ROIC (TTM)	-8881.0%	-4566.0%
Financial Health
Cash	$44M	$25M
Debt	$0	$26M
Net Cash/Debt	$44M	$-959K
Current Ratio (TTM)	3.81x	3.18x
Quick Ratio (TTM)	3.28x	2.75x
Debt/Equity (TTM)	0.00x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.78	2.28
52W Performance	-13.8%	-23.3%
YTD Performance	-29.1%	39.4%
% from 52W High	-53.0%	-31.2%
% from 52W Low	4.6%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	1.27x
FCF Yield (TTM)	-25.4%	-3.7%
Earnings Yield (TTM)	-32.1%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	10.2
EV/GP/RG	N/A	0.55
Ticker research	View UNCY research	View XGN research